Reintroduction of Oxaliplatin: A Viable Approach to the Long-Term Management of Metastatic Colorectal CancerGROTHEY, Axel.Oncology. 2010, Vol 79, Num 5-6, pp 389-399, issn 0030-2414, 11 p.Article

Biomarkers of Resistance to Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients with Metastatic Colorectal CancerBANCK, Michaela S; GROTHEY, Axel.Clinical cancer research (Print). 2009, Vol 15, Num 24, pp 7492-7501, issn 1078-0432, 10 p.Article

Future directions in vascular endothelial growth factor-targeted therapy for metastatic colorectal cancerGROTHEY, Axel.Seminars in oncology. 2006, Vol 33, Num 5, issn 0093-7754, S41-S49, SUP10Article

First- and second-line therapy of metastatic colorectal cancerTERSTRIEP, Shelby; GROTHEY, Axel.Expert review of anticancer therapy. 2006, Vol 6, Num 6, pp 921-930, issn 1473-7140, 10 p.Article

Biological Therapy and Other Novel Therapies in Early-Stage Disease : Are They Appropriate?GROTHEY, Axel.Clinical cancer research. 2007, Vol 13, Num 22, issn 1078-0432, 6909s-6912sConference Paper

Is there a third-line therapy for metastatic colorectal cancer?GROTHEY, Axel.Seminars in oncology. 2006, Vol 33, Num 6, issn 0093-7754, S36-S38, SUP11Conference Paper

Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatmentGROTHEY, Axel; SARGENT, Daniel; GOLDBERG, Richard M et al.Journal of clinical oncology. 2004, Vol 22, Num 7, pp 1209-1214, issn 0732-183X, 6 p.Article

A low dose of ionizing radiation increases luminal release of intestinal peptidases in ratsFITTKAU, Marina; GROTHEY, Axel; GERLACH, Reinhard et al.Journal of cancer research and clinical oncology. 2001, Vol 127, Num 2, pp 96-100, issn 0171-5216Article

Human hematopoietic growth factors : Old lessons and new perspectivesDEMPKE, Wolfram; VON POBLOZKI, Almut; GROTHEY, Axel et al.Anticancer research. 2000, Vol 20, Num 6D, pp 5155-5164, issn 0250-7005Article

Evaluation of Alternate Categorical Tumor Metrics and Cut Points for Response Categorization Using the RECIST 1.1 Data WarehouseMANDREKAR, Sumithra J; AN, Ming-Wen; MEYERS, Jeffrey et al.Journal of clinical oncology. 2014, Vol 32, Num 8, pp 841-850, issn 0732-183X, 10 p.Article

Chemotherapy in advanced gastric cancer : A systematic review and Meta-analysis based on aggregate dataWAGNER, Anna D; GROTHE, Wilfried; HAERTING, Johannes et al.Journal of clinical oncology. 2006, Vol 24, Num 18, pp 2903-2909, issn 0732-183X, 7 p.Article

Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)LOPRINZI, Charles L; RUI QIN; DAKHIL, Shaker R et al.Journal of clinical oncology. 2014, Vol 32, Num 10, pp 997-1005, issn 0732-183X, 9 p.Article

Comparison of Outcomes After Fluorouracil-Based Adjuvant Therapy for Stages II and III Colon Cancer Between 1978 to 1995 and 1996 to 2007: Evidence of Stage Migration From the ACCENT DatabaseQIAN SHI; ANDRE, Thierry; O'CONNELL, Michael J et al.Journal of clinical oncology. 2013, Vol 31, Num 29, pp 3656-3663, issn 0732-183X, 8 p.Article

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trialGROTHEY, Axel; VAN CUTSEM, Eric; ADENIS, Antoine et al.Lancet (British edition). 2013, Vol 381, Num 9863, pp 303-312, issn 0140-6736, 10 p.Article

Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7GROTHEY, Axel; NIKCEVICH, Daniel A; LOPRINZI, Charles L et al.Journal of clinical oncology. 2011, Vol 29, Num 4, pp 421-427, issn 0732-183X, 7 p.Article

Clinical Outcomes in Elderly Patients with Metastatic Colorectal Cancer Receiving Bevacizumab and Chemotherapy: Results from the BRiTE Observational Cohort StudyKOZLOFF, Mark F; BERLIN, Jordan; FLYNN, Patrick J et al.Oncology. 2010, Vol 78, Num 5-6, pp 329-339, issn 0030-2414, 11 p.Article

Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841FRANKO, Jan; QIAN SHI; GOLDMAN, Charles D et al.Journal of clinical oncology. 2012, Vol 30, Num 3, pp 263-267, issn 0732-183X, 5 p.Article

Prognostic Web-Based Models for Stage II and III Colon Cancer: A Population and Clinical Trials-Based Validation of Numeracy and Adjuvant! OnlineGILL, Sharlene; LOPRINZI, Charles; SARGENT, Daniel J et al.Cancer. 2011, Vol 117, Num 18, pp 4155-4165, issn 0008-543X, 11 p.Article

Adjuvant Chemotherapy for Resected Stage II and III Colon Cancer: Comparison of Two Widely Used Prognostic Calculators : Cancer prediction modelsBARDIA, Aditya; LOPRINZI, Charles; GROTHEY, Axel et al.Seminars in oncology. 2010, Vol 37, Num 1, pp 39-46, issn 0093-7754, 8 p.Article

Survival Following Recurrence in Stage II and III Colon Cancer : Findings From the ACCENT Data SetO'CONNELL, Michael J; CAMPBELL, Megan E; GOLDBERG, Richard M et al.Journal of clinical oncology. 2008, Vol 26, Num 14, pp 2336-2341, issn 0732-183X, 6 p.Article

Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer : Results From a Large Observational Cohort Study (BRiTE)GROTHEY, Axel; SUGRUE, Mary M; PURDIE, David M et al.Journal of clinical oncology. 2008, Vol 26, Num 33, pp 5326-5334, issn 0732-183X, 9 p.Article

Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : Intergroup trial n9741 in first-line treatment of metastatic colorectal cancerASHLEY, Amanda C; SARGENT, Daniel J; PITOT, Henry C et al.Cancer. 2007, Vol 110, Num 3, pp 670-677, issn 0008-543X, 8 p.Article

Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147GONSALVES, Wilson I; MAHONEY, Michelle R; HUBBARD, Joleen M et al.Journal of the National Cancer Institute. 2014, Vol 106, Num 7, issn 0027-8874, dju106.1-dju106.8Article

ACCENT-Based Web Calculators to Predict Recurrence and Overall Survival in Stage III Colon CancerRENFRO, Lindsay A; GROTHEY, Axel; YOTHERS, Greg et al.Journal of the National Cancer Institute. 2014, Vol 106, Num 12, issn 0027-8874, 333.1-333.9Article

Exploring Racial Differences in Outcome and Treatment for Metastatic Colorectal Cancer: Results From a Large Prospective Observational Cohort Study (BRiTE)POLITE, Blase N; SING, Amy; SARGENT, Daniel J et al.Cancer. 2012, Vol 118, Num 4, pp 1083-1090, issn 0008-543X, 8 p.Article